What is pembrolizumab (Keytruda) and is it used for Mesothelioma

Q: What is pembrolizumab (Keytruda) and is it used for Mesothelioma

Pembrolizumab is a type of immunotherapy drug called a checkpoint inhibitor. Here's how it works in plain language: Your immune system has "brakes" built in to prevent it from attacking your own healthy cells. Cancer cells are clever—they use these same brakes to hide from your immune system. Pembrolizumab works by releasing those brakes, essentially telling your immune cells: "This cancer is the enemy—attack it." Specifically, it blocks a protein called PD-1, which is why it's sometimes called

MesotheliomaMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Pembrolizumab (Keytruda) and Mesothelioma

What is Pembrolizumab?

Pembrolizumab is a type of immunotherapy drug called a checkpoint inhibitor. Here's how it works in plain language:

Your immune system has "brakes" built in to prevent it from attacking your own healthy cells. Cancer cells are clever—they use these same brakes to hide from your immune system. Pembrolizumab works by releasing those brakes, essentially telling your immune cells: "This cancer is the enemy—attack it." Specifically, it blocks a protein called PD-1, which is why it's sometimes called a "PD-1 inhibitor."

The FDA approved pembrolizumab (brand name Keytruda) for various cancers, and it's been a significant advance in immunotherapy treatment.

Is It Used for Mesothelioma?

Yes, pembrolizumab is used for mesothelioma, though typically in specific situations:

FDA Approval Status: Pembrolizumab is FDA-approved for mesothelioma, particularly for patients with unresectable (cannot be surgically removed) or metastatic (spread) pleural mesothelioma
Common Use: It's often used as a first-line treatment (initial treatment) for mesothelioma patients, sometimes combined with chemotherapy
Combination Therapy: Research has shown that combining pembrolizumab with traditional chemotherapy drugs (like pemetrexed and cisplatin) can be more effective than chemotherapy alone for some mesothelioma patients

Important Questions for Your Oncologist

If your care team is considering pembrolizumab for you, these questions can help guide your discussion:

Is pembrolizumab recommended for my specific type and stage of mesothelioma?
Would I receive it alone or combined with chemotherapy?
What are the expected benefits and potential side effects I should watch for?
How will my doctors monitor whether the treatment is working?
Are there clinical trials available that might be appropriate for my situation?

Key Considerations

Immunotherapy works differently than traditional chemotherapy—it can take longer to see results, and your body's immune response is doing the fighting. Not all patients respond equally well, which is why your oncologist's assessment of your individual case is crucial.

Your mesothelioma care team will evaluate factors like your overall health, specific mesothelioma subtype, and previous treatments to determine if pembrolizumab is the right choice for you.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Upload Records →Ask About Your Case →